A detailed history of Cubist Systematic Strategies, LLC transactions in Xencor Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 68,029 shares of XNCR stock, worth $1.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
68,029
Previous 101,653 33.08%
Holding current value
$1.6 Million
Previous $1.92 Million 28.9%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.7 - $21.65 $527,896 - $727,959
-33,624 Reduced 33.08%
68,029 $1.37 Million
Q2 2024

Aug 14, 2024

SELL
$18.21 - $24.5 $1.67 Million - $2.25 Million
-91,691 Reduced 47.42%
101,653 $1.92 Million
Q1 2024

May 15, 2024

BUY
$18.65 - $26.52 $1.05 Million - $1.49 Million
56,255 Added 41.04%
193,344 $4.28 Million
Q4 2023

Feb 14, 2024

BUY
$16.53 - $21.42 $1.88 Million - $2.43 Million
113,533 Added 481.97%
137,089 $2.91 Million
Q3 2023

Nov 14, 2023

BUY
$20.08 - $25.39 $473,004 - $598,086
23,556 New
23,556 $474,000
Q4 2022

Feb 14, 2023

BUY
$24.79 - $30.86 $228,836 - $284,868
9,231 New
9,231 $240,000
Q2 2022

Aug 15, 2022

BUY
$19.74 - $29.01 $2.77 Million - $4.07 Million
140,198 Added 249.1%
196,479 $5.38 Million
Q1 2022

May 16, 2022

BUY
$26.68 - $41.63 $1.19 Million - $1.86 Million
44,567 Added 380.46%
56,281 $1.5 Million
Q4 2021

Feb 14, 2022

SELL
$33.67 - $43.44 $249,764 - $322,237
-7,418 Reduced 38.77%
11,714 $470,000
Q3 2021

Nov 15, 2021

SELL
$30.65 - $35.68 $624,524 - $727,015
-20,376 Reduced 51.57%
19,132 $625,000
Q2 2021

Aug 16, 2021

BUY
$34.33 - $44.68 $620,961 - $808,171
18,088 Added 84.44%
39,508 $1.36 Million
Q1 2021

May 17, 2021

BUY
$40.81 - $53.88 $55,583 - $73,384
1,362 Added 6.79%
21,420 $922,000
Q4 2020

Feb 16, 2021

SELL
$36.63 - $47.63 $620,585 - $806,947
-16,942 Reduced 45.79%
20,058 $875,000
Q3 2020

Nov 16, 2020

BUY
$30.09 - $43.02 $497,267 - $710,948
16,526 Added 80.72%
37,000 $1.44 Million
Q2 2020

Aug 14, 2020

BUY
$27.76 - $33.42 $568,358 - $684,241
20,474 New
20,474 $663,000
Q1 2020

May 15, 2020

SELL
$20.69 - $37.79 $1.19 Million - $2.17 Million
-57,529 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$32.75 - $41.43 $1.55 Million - $1.97 Million
47,475 Added 472.2%
57,529 $1.98 Million
Q3 2019

Nov 14, 2019

BUY
$33.73 - $46.27 $339,121 - $465,198
10,054 New
10,054 $339,000
Q2 2019

Aug 14, 2019

SELL
$29.6 - $40.93 $95,371 - $131,876
-3,222 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$27.85 - $38.09 $89,732 - $122,725
3,222 New
3,222 $100,000
Q4 2018

Feb 14, 2019

SELL
$32.39 - $42.05 $199,781 - $259,364
-6,168 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$35.69 - $47.65 $220,135 - $293,905
6,168 New
6,168 $240,000
Q4 2017

Feb 14, 2018

SELL
$19.29 - $24.83 $15,567 - $20,037
-807 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$19.61 - $23.35 $15,825 - $18,843
807
807 $18,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.4B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.